Sechi1 was challenged by our reporting of no increased glomerular filtration rate (GFR) in
primary aldosteronism (PA) patients, as compared with patients with primary hypertension …

In 1953, Lipicki published in Polish the first report of a case of arterial hypertension and
hypokalemia caused by an adrenocortical adenoma, which remained unnoticed until …

Objective: The aim of the study was to evaluate the changes in eGFR in patients with
idiopathic primary aldosteronism (IHA) and with aldosterone-secreting adenoma (APA) after …

Primary aldosteronism (PA) is the most common form of endocrine hypertension, due to
autonomous aldosterone production from the adrenal cortex. Patients with PA typically …

Primary aldosteronism (PA), characterized by inappropriately high concentrations of the
adrenal derived hormone aldosterone, is the most common endocrine cause of arterial …

Primary aldosteronism (PA) has been associated with cardiovascular hypertrophy and
fibrosis, in part independent of the blood pressure level, but deleterious effects on the …

Although primary aldosteronism (PA) has long been considered a rare cause of
hypertension, recent reports suggest that the prevalence of PA among hypertensive patients …

Primary aldosteronism (PA), first described by Jerome W. Conn in 1955 [1], is characterized
by excessive, autonomous aldosterone production relative to suppressed plasma renin. PA …

After discussing in Part I (Rossi et al, J Nephrol. 2008; 21: 447-454) the screening strategy to
identify the hypertensive patients with primary aldosteronism (PA), we report here an update …

Objective: In experimental animal models a significant association between exogenous
aldosterone excess and the progression of renal disease has been observed. However, the …